pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

2,184 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT967Endpoints742BioPharma Dive283BioSpace181Fierce Biotech172onclive165globenewswire health73raps
therapy area
allOncology5621Rare Disease1252Cardiology1054Hematology940Immunology932Vaccines816Pulmonology
  • Uncertainty persists over food source of summer cyclospora outbreak, officials say
    A parasite called cyclospora has infected nearly 7,000 people across 34 states this summer, marking one of the largest surges on record. Michigan health officials have identified lettuce and salad…
    STAT · 1mo agoNegative↗ source
  • CDC reports surge in cyclosporiasis cases, over 1,600 confirmed in U.S.
    The Centers for Disease Control and Prevention has confirmed more than 1,600 cases of cyclosporiasis, a parasitic infection that causes diarrhea, across the United States. An additional 5,100 cases…
    STAT · 1mo agoNeutral↗ source
← prev
page 35 of 88
next →
65
fda recalls41
fda medwatch32
fda press25
782
Psychiatry & CNS691
Ophthalmology347
Pain342
Endocrinology & Metabolism340
Infectious Disease331
Veradermics reports first positive efficacy data for oral minoxidil in women with pattern hair loss
Veradermics announced that its oral formulation of minoxidil demonstrated positive efficacy in a mid‑stage trial involving women with pattern hair loss. The results mark the company's first effica…
Endpoints · 1mo agoPositive readoutPositive↗ source
  • Mwyngil Therapeutics launches obesity program that avoids GLP-1 pathway
    Mwyngil Therapeutics, a newly formed biotech startup, is pursuing obesity treatments that do not target the GLP-1 receptor, a pathway that has dominated recent weight-loss drug development. CEO Lu…
    STAT · 1mo agoNeutral↗ source
  • Scientists and stakeholders overwhelmingly oppose White House grantmaking overhaul, analysis finds
    Researchers at the University of North Carolina at Chapel Hill, working with STAT, examined a flood of public comments on a White House proposal to revamp the federal "Uniform Guidance" that govern…
    STAT · 1mo agoRegulatoryNegative↗ source
  • Senator Lindsey Graham's death from aortic dissection spotlights need for better screening
    Senator Lindsey Graham died at age 71 after suffering an aortic dissection, drawing public attention to this rare but deadly condition. An aortic dissection occurs when the body's main blood vesse…
    STAT · 1mo agoNegative↗ source
  • Ebola outbreak in eastern Congo accelerates, 80% of new cases from unknown transmission chains
    WHO emergencies chief Chikwe Ihekweazu said the Ebola outbreak in eastern Congo is outpacing response efforts, noting that many recent deaths occurred in communities without reaching health facilit…
    STAT · 1mo agoNegative↗ source
  • FTC settlement forces CVS Caremark to change insulin pricing, could save US patients $8.5 billion
    The Federal Trade Commission announced it has settled a lawsuit against CVS Caremark, one of the nation's largest pharmacy benefit managers, over claims the company inflated insulin prices and rest…
    STAT · 1mo agoRegulatoryPositive↗ source
  • 340B Drug Discount Program sales hit $100 billion in 2025, up 22.8% year over year
    The Health Resources and Services Administration reported that purchases under the 340B discount program reached $100 billion in 2025, a 22.8% rise from 2024. Expensive medicines made up a growing…
    STAT · 1mo agoRegulatoryNeutral↗ source
  • HCA Healthcare cuts 2026 profit outlook as uninsured patient numbers rise after ACA subsidy expiration
    HCA Healthcare, the largest U.S. hospital chain, announced on Tuesday that it is lowering its profit outlook for 2026. The revision reflects a higher-than-expected number of uninsured patients in…
    STAT · 1mo agoNegative↗ source
  • Biogen’s experimental Alzheimer’s drug diranersen slows cognitive decline in Phase 2, matching approved therapies
    Biogen reported that its experimental Alzheimer’s therapy diranersen slowed cognitive decline in a mid-stage Phase 2 study, achieving decline rates similar to those seen with drugs already on the m…
    STAT · 1mo agoPositive readoutPositive↗ source
  • Celcuity receives FDA approval for Revtorpyk breast cancer therapy
    Celcuity, a small public biotech, announced that the U.S. Food and Drug Administration has cleared its drug Revtorpyk for use in breast cancer patients when combined with fulvestrant. The approval…
    Endpoints · 1mo agoApprovalPositive↗ source
  • Bipartisan Bill to Limit US Biotech Deals with China Remains in Limbo
    A bipartisan bill introduced in the House seeks to bar U.S. biotechnology firms from entering into collaborations or licensing agreements with Chinese companies. The proposal sparked strong reacti…
    Endpoints · 1mo agoRegulatoryNeutral↗ source
  • Live webcast examines why biotech IPOs are gaining momentum again
    Drew Armstrong, executive editor at Endpoints News, announced a live webcast scheduled for July 15 at 12 p.m. ET. The session will feature Parabilis CEO Mathai Mammen and Kailera CEO Ron Renaut, al…
    Endpoints · 1mo agoPositive↗ source
  • Erasca seeks $550M in public offering to fund KRAS drug development
    Erasca announced a public offering targeting $550 million to advance its KRAS-targeted drug program. The biotech said the capital will support ongoing research and potential clinical trials for its…
    Endpoints · 1mo agoDealNeutral↗ source
  • AI drug-discovery startup Chai Discovery raises $400 million in Series C, tripling its valuation
    Chai Discovery, a startup focused on using artificial intelligence for drug discovery, announced a new Series C financing round that brought in $400 million. The capital injection was led by existi…
    Endpoints · 1mo agoDealPositive↗ source
  • Biogen's tau therapy shows mixed Alzheimer's results, low dose outperforms higher dose
    At the Alzheimer's Association International Conference in London, Biogen presented data on its experimental tau‑targeting therapy for Alzheimer's disease. The trial showed that the drug produced…
    Endpoints · 1mo agoNegative readoutNeutral↗ source
  • Anthropic launches Claude Science AI platform for biotech labs in Kendall Square
    Anthropic has introduced Claude Science, an application that tailors its large language model for use in biopharma research laboratories. The tool is being positioned for the Kendall Square biotech…
    STAT · 1mo agoNeutral↗ source
  • California settles with bankrupt Carbon Health, signaling crackdown on digital health workarounds
    At the end of June, California's attorney general reached a settlement with Carbon Health, a clinic operator that has filed for bankruptcy. The settlement follows accusations from the state Justic…
    Endpoints · 1mo agoRegulatoryNegative↗ source
  • Former Akero executives team up with Fairmount to launch new immunology company
    The former executive team of Akero Therapeutics, which was recently acquired by Novo Nordisk, has announced the formation of a new immunology-focused company. They are partnering with investment fi…
    STAT · 1mo agoNeutral↗ source
  • US appeals court revives Teva lawsuit alleging Lilly breached generic Forteo agreement
    A U.S. appeals court has revived a lawsuit filed by Teva Pharmaceuticals against Eli Lilly. The case alleges that Lilly broke an agreement that permitted Teva to sell a generic version of Lilly's o…
    STAT · 1mo agoNegative↗ source
  • Draig Therapeutics raises $65 million Series B to push depression drug targeting synapse repair
    Draig Therapeutics announced it has closed a $65 million Series B financing round that was oversubscribed. The capital will be used to advance its neuropsychiatry pipeline, with the lead program f…
    Endpoints · 1mo agoDealPositive↗ source
  • Lyora Therapeutics launches to revive early-stage genetic eye disease programs from Editas and Biogen
    Lyora Therapeutics announced its formation as a new genetic‑medicine company focused on eye diseases. The firm will take over several early‑stage programs that were previously in the pipelines of E…
    Endpoints · 1mo agoPositive↗ source
  • Cyclospora infections hit record high in 2026, Michigan officials suspect lettuce as source
    Infections caused by the parasite Cyclospora have surged to a record level in 2026, with more than 30 states reporting cases that now exceed the previous U.S. high of about 4,700 set in 2019. The…
    STAT · 1mo agoNegative↗ source
  • Democratic senators raise concerns over credibility and conflicts in RFK Jr.'s health-care advisory panel
    Two senior Democratic senators sent a letter to Health Secretary Robert F. Kennedy Jr. and CMS Administrator Mehmet Oz, saying they have serious concerns about the credibility and financial conflic…
    STAT · 1mo agoRegulatoryNegative↗ source